A University of Chicago team is exploring how a series of cooking classes, focused on nutrition and making better food choices, impact participants’ gastrointestinal microbiomes and overall health. Supported in part by the GI Research Foundation, they are seeing quick improvements to participants’ gut health that may motivate people to keep eating better.

Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.

Fortifeye Vitamins, with Dr. Michael Lange, discuss protein

The Study, Conducted by Endominance, HEM Pharma, and Gene1on1, Aims to Better Understand How a Gut-Derived Metabolite Combined with Variations in Cognitive Orientation Are Associated with Anxiety.

The subscription-based wellness brand presents its first supplement lines with two scientifically-supported products.

National ad campaign will encourage patients to ask doctors about superior NGS diagnostics

Clinical research using MicroGenDX molecular testing highlights diagnostic applications

Nemysis Ltd. announced today the appointment of David S. Sanders, MD, to its Scientific Advisory Board (SAB).

Nemysis Ltd announced today the appointment of Dr. Alessio Fasano to its Scientific Advisory Board (SAB)

The Study, Conducted by Endominance, F1RST and Psomagen, Aims to Better Understand how First Responders' Work Environment Impacts Their Cognitive, Mental, Physical, and Microbiome State

Nemysis Ltd Announces Grant of First Chinese Patent for IHAT, the Novel Iron Nanoparticulate Supplement for Iron Deficiency (ID) and Iron Deficiency With Anemia (IDA).

Nemysis Ltd today announces the appointment of internationally recognized drug discovery and development expert Linda Cavaletti to its Scientific Advisory Board (SAB).

Nemysis Limited, the Dublin-based pharmaceutical and healthcare Company focused on iron deficiency/anemia and gluten sensitivity has announced that it has completed a €2.65M capital raise.

"America Needs Less Hand Sanitizer and More Bacteria Love," Says Dr. Maddahi

Leading Beverly Hills Dentist Reveals Top Tips for Protecting the Oral Microbiome and Improving Immune Response

Ultimate IgG works to neutralize antigens, calm autoimmune responses, support a strong gut barrier, and boost the effectiveness of probiotics.

International genetic testing company Dante Labs launches ambitious project to improve oral and dental care through the study of the microbes in the oral cavity

A new computational approach from the Gladstone Institutes identifies genes that may help microbes live successfully in the human gut

Adds 4 trademarks - Nutrafer™, Dietofer™ and IDAXTM in Iron Deficiency and TolPlus™ in Gluten Intolerance

Astarte Medical awarded support to help advance microbiome-based human health solutions

An unexpected collaboration leads to the discovery of an early predictor of IBD

LoveBug® Probiotics Launches New Probiotic Formula For Moms-To-Be

It provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the human microbiome market along with the estimates and forecasts of the revenue and share analysis.

More than just a protein powder, TRUProteins Nutra Whey continues to improve the nutritional value of the formula by adding a probiotic to promote healthy bacteria in the body, improving overall health and wellness.

We are pleased to announce that we are changing our company name from PhyloTech to Second Genome.